News

MAGIC-AML

05/03/2026

MAGIC-AML – Multiarm, Multicenter, RAndomized, Molecularly-GuIded Controlled Trial of Personalized Treatment Strategy – of Acute Myeloid Leukemia

cALL-POL

05/03/2026

Childhood ALL in Poland (cALL-POL) project: a national harmonization of diagnostics and treatment of acute lymphoblastic leukemia in children

COMBO-UC trial

05/03/2026

Comparison of ustekinumab, infliximab and COMBinatiOn therapy in moderately-to-severely active Ulcerative Colitis – the head to head COMBO-UC trial

PICOLO-FH

03/03/2026

TYTUŁ PROJEKTU: ComParison of InClisiran Or aLirOcumab to standard therapy in pediatric Familial Hypercholesterolemia – the head-to-head PICOLO-FH clinical trial

SHIELD-Fabry

02/03/2026

Low-dose corticosteroids adjacent to enzyme replacement therapy or chaperon therapy in patients with cardiac manifestation of Fabry disease – prospective

cALL-POL

15/09/2025

TYTUŁ PROJEKTU: Childhood ALL in Poland (cALL-POL) project: a national harmonization of diagnostics and treatment of acute lymphoblastic leukemia in children

Competition for non-commercial clinical trials – ABM/2025/1

10/04/2025

On April 08, 2025, the Medical Research Agency (ABM) published the Competition Regulations for: „Open competition for non-commercial clinical trials– ABM/2025/1”.

Konkurs-2024ABM7KPO-CWBK2-WWW-NOWY-WYMIAR

The CWBK2 project has been recommended for funding under Competition 2024/ABM/7/KPO

14/02/2025

We are very pleased to announce that the Project “CWBK2 ” has been recommended for funding under the Competition 2024/ABM/7/KPO.

Recomendation – ABM20241 www FABRY NOWY WYMIAR ANG

The SHIELD-Fabry project has been recommended for funding under Competition ABM/2024/1

07/11/2024

We are very pleased to announce that the Project “SHIELD-Fabry ” has been recommended for funding under the Competition ABM/2024/1.

Competition ABM/2023/1

10/03/2023

On March 10, 2023, the Medical Research Agency (ABM) published the Competition Regulations for: “Competition for non-commercial clinical trials or